Cardiex Receives TGA Approval for CONNEQT Pulse Arterial Health Monitor

Cardiex receives TGA approval for CONNEQT Pulse arterial health monitor

Cardiex’s CONNEQT Pulse device approved by the TGA, enabling Australian market entry Approval follows earlier FDA clearance and supports broader CONNEQT Health platform expansion $6.5m capital raise underway to fund manufacturing, sales and digital platform growth   Special Report: Health technology company Cardiex has achieved an important milestone, receiving Therapeutic Goods Administration (TGA) approval for its CONNEQT Pulse arterial health…

Cardiex Receives TGA Approval for CONNEQT Pulse Device

Cardiex Limited (CDX:AU) has announced Cardiex Receives TGA Approval for CONNEQT Pulse Device Download the PDF here. This post appeared first on investingnews.com

Cardiex wins TGA greenlight; shares jump +11%

Cardiex Ltd (ASX:CDX) has popped +11% intraday to 4.7cps as the smallcap healthcare stock wins a key approval from the TGA. That relates to its flagship ‘Conneqt Pulse’ device, which is ultimately a smartphone-compatible cardiovascular health biometrics tracking product. “The Pulse is a world-first clinical-grade vascular biometric monitoring device designed for use in both clinical and remote patient monitoring or at-home … it enables the captu…